Page last updated: 2024-08-23

etoposide and Pruritus

etoposide has been researched along with Pruritus in 3 studies

Research

Studies (3)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	1 (33.33)	18.2507
2000's	1 (33.33)	29.6817
2010's	1 (33.33)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Frouin, E; Hainaut, E; Puyade, M; Rioli, DI; Walter, A	1
Alonso-Llamazares, J; Marchione, R; Ricotti, C; Romanelli, P; Shiman, M	1
Hendrick, A	1

Reviews

1 review(s) available for etoposide and Pruritus

Article	Year
CD4+/CD56+ Hematodermic neoplasm (plasmacytoid dendritic cell tumor). Dermatology online journal, 2008, Nov-15, Volume: 14, Issue:11 Topics: Antineoplastic Combined Chemotherapy Protocols; CD4 Antigens; CD56 Antigen; Cyclophosphamide; Daunorubicin; Dexamethasone; Doxorubicin; Etoposide; Humans; Immunophenotyping; Killer Cells, Natural; Lymphoma, T-Cell, Cutaneous; Male; Middle Aged; Pruritus; Remission Induction; Vincristine	2008

Article

Year

CD4+/CD56+ Hematodermic neoplasm (plasmacytoid dendritic cell tumor).

Dermatology online journal, 2008, Nov-15, Volume: 14, Issue:11

Topics: Antineoplastic Combined Chemotherapy Protocols; CD4 Antigens; CD56 Antigen; Cyclophosphamide; Daunorubicin; Dexamethasone; Doxorubicin; Etoposide; Humans; Immunophenotyping; Killer Cells, Natural; Lymphoma, T-Cell, Cutaneous; Male; Middle Aged; Pruritus; Remission Induction; Vincristine

2008

Other Studies

2 other study(ies) available for etoposide and Pruritus

Article	Year
Efficacy of etoposide for myelodysplasia cutis. European journal of dermatology : EJD, 2018, 04-01, Volume: 28, Issue:2 Topics: Administration, Oral; Aged, 80 and over; Antineoplastic Agents, Phytogenic; Biopsy, Needle; Dose-Response Relationship, Drug; Drug Administration Schedule; Etoposide; Follow-Up Studies; Humans; Immunohistochemistry; Male; Myelodysplastic Syndromes; Pruritus; Severity of Illness Index; Skin Neoplasms; Treatment Outcome	2018
Psychosis during interferon in eosinophilic leukaemia. Clinical and laboratory haematology, 1994, Volume: 16, Issue:3 Topics: Adolescent; Adrenal Cortex Hormones; Antineoplastic Combined Chemotherapy Protocols; Combined Modality Therapy; Cyclophosphamide; Cytarabine; Delusions; Diagnosis, Differential; Epirubicin; Etoposide; Fatal Outcome; Hemibody Irradiation; Humans; Hydroxyurea; Hypereosinophilic Syndrome; Immunologic Factors; Interferon-alpha; Leukemic Infiltration; Male; Palliative Care; Pruritus; Skin; Somatoform Disorders; Splenectomy; Vasculitis; Vincristine	1994

Article

Year

Efficacy of etoposide for myelodysplasia cutis.

European journal of dermatology : EJD, 2018, 04-01, Volume: 28, Issue:2

Topics: Administration, Oral; Aged, 80 and over; Antineoplastic Agents, Phytogenic; Biopsy, Needle; Dose-Response Relationship, Drug; Drug Administration Schedule; Etoposide; Follow-Up Studies; Humans; Immunohistochemistry; Male; Myelodysplastic Syndromes; Pruritus; Severity of Illness Index; Skin Neoplasms; Treatment Outcome

2018

Psychosis during interferon in eosinophilic leukaemia.

Clinical and laboratory haematology, 1994, Volume: 16, Issue:3

Topics: Adolescent; Adrenal Cortex Hormones; Antineoplastic Combined Chemotherapy Protocols; Combined Modality Therapy; Cyclophosphamide; Cytarabine; Delusions; Diagnosis, Differential; Epirubicin; Etoposide; Fatal Outcome; Hemibody Irradiation; Humans; Hydroxyurea; Hypereosinophilic Syndrome; Immunologic Factors; Interferon-alpha; Leukemic Infiltration; Male; Palliative Care; Pruritus; Skin; Somatoform Disorders; Splenectomy; Vasculitis; Vincristine

1994